Pressure BioSciences Inc. to Join University's R&D Facility
Boston, MA (Vocus) January 21, 2010 -- The University of Massachusetts Boston today announced that South Easton-based Pressure BioSciences Inc., (PBI) a developer of bench-top sample preparation instruments, has moved its research and development operations to the university's Venture Development Center. PBI develops and markets pressure cycling technology that enables safe, rapid, and reproducible extraction of proteins, DNA, RNA, and small molecules from biological samples for biochemical analysis.
This brings the 18,000-square-foot business incubator to 75 percent occupancy since opening in May 2009.
The addition of PBI is expected to greatly benefit the Center for Personalized Cancer Therapy, a joint UMass Boston venture with the Dana-Farber/Harvard Cancer Center to be launched within the VDC. The purpose of the CPCT is to conduct basic and translational research to develop low-cost diagnostic tests focusing on cancers that vary at the molecular level but remain indistinguishable in conventional clinical analyses.
“Our scientists connected with the Center for Personalized Cancer Therapy are excited about collaborating with PBI," said William Brah, executive director of the VDC. “The goals of CPCT are ideally complemented by the cutting-edge, PCT-based sample preparation technology developed by PBI, which can permit tumor biomarkers in ordinary clinical preparations to be more rapidly and effectively analyzed.”
Copyright©2010 Vocus, Inc.
All rights reserved